Login
$UPB
$2.18 +$0.03 (1.4%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
E. Rand Sutherland, M.D. Also a director
Chief Executive Officer
Title from the Form 4 dated Sep 16, 2026
56 Not stated Not stated $4,302,100
Michael Paul Gray
CFO and COO
Title from the Form 4 dated Sep 16, 2026
55 Not stated 2024 $1,993,437
Adam Houghton
Chief Business Officer
55 Since 2021
5 years
Not stated Not reported
Allison Ambrose
Sr. Vice President, General Counsel and Secretary
41 Not stated Not stated Not reported
Aaron Deykin
Chief Medical Officer and Head of Research and Development
60 Since 2022
4 years
Not stated $1,830,916

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
3.6 years
from year joined
CEO also chairs the board
No
Ronald C. Renaud, Jr., M.B.A.
Director Age On board Independent Committees Other public boards 2025 pay Source
Ronald C. Renaud, Jr., M.B.A.
57 2021
5 years
Independent None stated Kailera Therapeutics, Inc. $231,010
E. Rand Sutherland, M.D.
56 2024
2 years
Not independent None stated Krystal Biotech, Inc. Paid as CEO
H. Edward Fleming, Jr., M.D.
63 2023
3 years
Independent
audit committee nominating and corporate governance committee
CRISPR Therapeutics AG, Sionna Therapeutics, Inc. $201,510
Liam Ratcliffe, M.B.Ch.B., Ph.D., M.B.A.
62 2021
5 years
Independent None stated Disc Medicine, Inc. $202,510
Daniella Beckman
47 2024
2 years
Independent None stated Vor Biopharma Inc. Not stated
Erez Chimovits, M.B.A., M.Sc.
62 2021
5 years
Independent None stated None stated $196,810
Marcella Kuhlman Ruddy, M.D., M.S.
63 2023
3 years
Independent None stated Sionna Therapeutics, Inc. $199,010

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 16, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support